EUVIMEDEUVIMED entdecken
Crossref

Comparison of short-term outcomes in thalassemia major ABO mismatch versus ABO compatible in allogeneic hematopoietic stem cell transplant

Mitraj Sinh Chudasma, Priya Marwah, Nikita Yadav, Uvesh Chouhan, Rachna Narain

Journal of Hematology and Allied Sciences · 2026

DOI: 10.25259/jhas_12_2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hematology and Allied Sciences, 2026. Verfasst von Mitraj Sinh Chudasma und 4 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for thalassemia major. ABO incompatibility between donor and recipient is common, but its clinical significance remains uncertain. The objective of the study is to assess the impact of ABO mismatch on outcomes of HSCT in patients with thalassemia major.

Methods

This ambispective single-center study included 102 patients with thalassemia major who underwent allogeneic HSCT between March 2012 and July 2023. Patients were equally divided into ABO-compatible ( n = 51) and ABO-mismatched ( n = 51) groups. Outcomes analyzed included acute graft-versus-host disease (aGVHD) and chronic graft-versus-host disease, autoimmune hemolytic anemia (AIHA), transplant-related mortality (TRM), overall survival (OS), and thalassemia-free survival (TFS).

Results

ABO-mismatched transplants showed significantly higher rates of aGVHD ( p = 0.0002) and AIHA ( p = 0.004) and higher TRM ( p = 0.031). However, OS ( p = 0.293) and TFS ( p = 0.554) were comparable between the two groups.

Conclusion

ABO incompatibility increases early post-transplant complications but does not significantly affect long-term survival outcomes. Human leukocyte antigen matching should remain the primary criterion in donor selection.

Zitieren

APA

Chudasma, M. S., Marwah, P., Yadav, N., Chouhan, U., & Narain, R. (2026). Comparison of short-term outcomes in thalassemia major ABO mismatch versus ABO compatible in allogeneic hematopoietic stem cell transplant. Journal of Hematology and Allied Sciences. https://doi.org/10.25259/jhas_12_2026

Vancouver

Chudasma MS, Marwah P, Yadav N, Chouhan U, Narain R. Comparison of short-term outcomes in thalassemia major ABO mismatch versus ABO compatible in allogeneic hematopoietic stem cell transplant. Journal of Hematology and Allied Sciences. 2026. doi:10.25259/jhas_12_2026

BibTeX
@article{Chudasma2026,
  author = {Chudasma, Mitraj Sinh and Marwah, Priya and Yadav, Nikita and Chouhan, Uvesh and Narain, Rachna},
  title = {Comparison of short-term outcomes in thalassemia major ABO mismatch versus ABO compatible in allogeneic hematopoietic stem cell transplant},
  journal = {Journal of Hematology and Allied Sciences},
  year = {2026},
  doi = {10.25259/jhas_12_2026}
}
Kostenlos starten →